To explore the molecular mechanism underlying the oncogenic role of Eag1 in liposarcoma, we focused on p38 MAPK pathway because Eag1 has been shown to activate p38 MAPK pathway [22], which is frequently activated in a variety of tumors [23]. The gene discussed is KCNH1; the disease is liposarcoma.